I am a
Home I AM A Search Login

Papers of the Week

2021 Jan 13

Rev Med Suisse



[Nephrology : what’s new in 2020 ?]


Saudan P, De Seigneux S, Haidar F
Rev Med Suisse. 2021 Jan 13; 17(720-1):54-58.
PMID: 33443832.


Impact of gliflozines in the treatment of non-diabetic nephropathies and cardiac failure has lately been demonstrated. Tolvaptan has now been recognized in Switzerland as a treatment of hyponatremia. In hemodialysis, some progress has been made in the management of dysfunctional arterio-venous fistulas. A glimmer of hope in the treatment of uremic pruritus? Conservative management of a stable coronary heart disease is also advocated in patients with end-stage kidney disease. Therapy with immune cells may either minimize or remove the need for immunosuppression in renal transplant patients. A new predictive score combining several markers can predict long-term graft failure.